CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing.
The average of price targets set by Wall Street analysts indicates a potential upside of 58.3% in CRISPR Therapeutics (CRSP). While the effectiveness of this highly sought-after metric is ...
At the same time, CRISPR Cas approaches are now entering the clinic and the very first clinical results seem to show promise.” What are your thoughts on the developing regulatory expectations ...
In a study published in the Dec. 5 issue of Nature, a team of researchers discovered a new population of neurons that is responsive to the hormone leptin. Leptin responsive neurons are important in ...
Dec. 3, 2024 — Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and ...
Nov. 13, 2024 — The Huntington's disease (HD) mutation eventually causes a fatal brain disease in adulthood, but a new study finds that early in life, children with ... Researchers Uncover ...
This limits the wide impact of this study but can be used as a starting point to examine sex- and age differences in the transcriptome due to alternative splicing. Complex diseases often exhibit ...
This report provides an update on the landscape of Article 8 and Article 9 funds at the end of September 2024, examining aspects such as flows, assets, product launches and closures, fund name ...